Cargando…
The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor intervention
PURPOSE: Studies of SF1126, an RGDS targeted, water-soluble prodrug of LY294002, are currently nearing completion in two adult Phase I trials. Herein, we performed a preclinical evaluation of SF1126 as a PI-3K inhibitor for Phase I trials in the treatment of recurrent neuroblastoma (NB). METHODS: Th...
Autores principales: | Peirce, Susan K., Findley, Harry W., Prince, Chengyu, Dasgupta, Anindya, Cooper, Todd, Durden, Donald L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143317/ https://www.ncbi.nlm.nih.gov/pubmed/20972874 http://dx.doi.org/10.1007/s00280-010-1486-7 |
Ejemplares similares
-
Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy
por: Ksionda, Olga, et al.
Publicado: (2018) -
PI 3-kinase and disease
por: Cantley, Lewis C
Publicado: (2012) -
PI 3-kinase and disease
por: Cantley, Lewis C
Publicado: (2014) -
Neuroprotective Role of the PI3 Kinase/Akt Signaling Pathway in Zebrafish
por: Chen, Shuang, et al.
Publicado: (2017) -
Polo-like kinase 4 mediates epithelial–mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathway
por: Tian, Xiangdong, et al.
Publicado: (2018)